Circulating TIMP-1 levels have been associated with poor prognosis in a community-based cohort of elderly men risk [22], patients with coronary artery disease [23], and in different cancer types, such as lung [24] breast [25] colorectal [26] and gastric cancer [27]. The gene discussed is TIMP1; the disease is coronary artery disorder.